Yıl: 2024 Cilt: 16 Sayı: 1 Sayfa Aralığı: 11 - 20 Metin Dili: İngilizce DOI: 10.4274/jcrpe.galenos.2023.2023-12-12 İndeks Tarihi: 11-06-2024

Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences

Öz:
Objective: Cardiovascular diseases (CVD) are the most important cause of morbidity and mortality in patients with type 1 diabetes (T1D). Children with T1D have a similar or higher prevalence of being overweight (OW) or obese (Ob) compared to healthy peers. The aim of this study was to determine the prevalence of CVD risk factors in children and adolescents with T1D and the impact of obesity and sex differences on these factors. Methods: Data of patients aged 10-21 years and who had been using intensive insulin therapy with a diagnosis of T1D for at least three years were evaluated. Patients were divided into normal weight (NW), OW and Ob groups based on body mass index percentiles. Risk factors for CVD (obesity, dyslipidemia, hypertension) were compared between groups, and impact of gender was also analyzed. Results: Data of 365 patients (200 girls, 54.8%), were evaluated. Prevalence of OW/Ob was 25.9% and was significantly higher in girls (30.6% vs 20.1%, p<0.001). Rate of hypertension was highest in OW/Ob girls followed by OW/Ob boys, and similar in NW girls and boys (p=0.003). Mean low density lipoprotein cholesterol (LDL-c) and triglyceride (TG) levels were highest in OW/Ob girls, followed by OW/Ob boys, NW girls and NW boys, respectively (p<0.001 and p<0.001, respectively). Mean high density lipoprotein-cholesterol (HDL-c) levels were similar among groups. Rates of high LDL-c and TG were similar between OW/Ob girls and boys and higher than NW girls, followed by NW boys (p<0.001 and p<0.001, respectively). The rate of low HDL-c was similar in OW/Ob girls and boys, and higher than NW girls, followed by NW boys (p<0.001). Overall, girls were 1.9 times more likely than boys to have two or more risk factors for CVD. Factors associated with risk for CVD in multiple logistic regression analyses were being a girl, followed by higher daily insulin dose, higher hemoglobin A1c, and longer duration of diabetes (r=0.856; p<0.001). Conclusion: In spite of the increased prevalence for obesity in both sexes, the trend for CVD risk factors was greater in Ob girls, followed by Ob boys and NW girls. Girls with T1D are more likely to be OW/Ob and to have CVD risk than boys, highlighting the need for early intervention and additional studies to elucidate the causes.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Rawshani A, Rawshani A, Gudbjörnsdottir S. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med 2017;377:300-301.
  • 2. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 2006;29:798-804.
  • 3. Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimäki T, Rönnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004;109:1750-1755. Epub 2004 Mar 15
  • 4. Park MH, Falconer C, Viner RM, Kinra S. The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review. Obes Rev 2012;13:985-1000. Epub 2012 Jun 26
  • 5. Valerio G, Iafusco D, Zucchini S, Maffeis C; Study-Group on Diabetes of Italian Society of Pediatric Endocrinology and Diabetology (ISPED). Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. Diabetes Res Clin Pract 2012;97:99-104. Epub 2012 Feb 13
  • 6. Liu LL, Lawrence JM, Davis C, Liese AD, Pettitt DJ, Pihoker C, Dabelea D, Hamman R, Waitzfelder B, Kahn HS; SEARCH for Diabetes in Youth Study Group. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 2010;11:4-11. Epub 2009 May 15
  • 7. Islam ST, Abraham A, Donaghue KC, Chan AK, Lloyd M, Srinivasan S, Craig ME. Plateau of adiposity in Australian children diagnosed with Type 1 diabetes: a 20-year study. Diabet Med 2014;31:686-690. Epub 2014 Mar 6
  • 8. Baskaran C, Volkening LK, Diaz M, Laffel LM. A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial. Pediatr Diabetes 2015;16:263-270. Epub 2014 Jul 12
  • 9. Fröhlich-Reiterer EE, Rosenbauer J, Bechtold-Dalla Pozza S, Hofer SE, Schober E, Holl RW; DPV-Wiss Study Group and German BMBF Competence Networks Diabetes mellitus and Obesity. Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German/Austrian DPV multicentre survey. Arch Dis Child 2014;99:738-743. Epub 2014 May 8
  • 10. Kapellen TM, Gausche R, Dost A, Wiegand S, Flechtner-Mors M, Keller E, Kiess W, Holl RW; DPV-Science-Initiative of the German Competence Network Diabetes and the German Competence Network Obesity (Consortium LARGE). Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database. J Pediatr Endocrinol Metab 2014;27:209-214.
  • 11. Holl RW, Grabert M, Sorgo W, Heinze E, Debatin KM. Contributions of age, gender and insulin administration to weight gain in subjects with IDDM. Diabetologia1998;41:542-547.
  • 12. Maahs DM, Daniels SR, de Ferranti SD, Dichek HL, Flynn J, Goldstein BI, Kelly AS, Nadeau KJ, Martyn-Nemeth P, Osganian SK, Quinn L, Shah AS, Urbina E; American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council for High Blood Pressure Research, and Council on Lifestyle and Cardiometabolic Health. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation 2014;130:1532-1558. Epub 2014 Aug 28
  • 13. Redondo MJ, Foster NC, Libman IM, Mehta SN, Hathway JM, Bethin KE, Nathan BM, Ecker MA, Shah AC, DuBose SN, Tamborlane WV, Hoffman RP, Wong JC, Maahs DM, Beck RW, DiMeglio LA. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol 2016;53:271-277. Epub 2015 Jun 16
  • 14. Pinhas-Hamiel O, Levek-Motola N, Kaidar K, Boyko V, Tisch E, Mazor- Aronovitch K, Graf-Barel C, Landau Z, Lerner-Geva L, Frumkin Ben- David R. Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus. Diabetes Metab Res Rev 2015;31:76-84.
  • 15. Donaghue K, Jeanne Wong SL. Traditional Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes Mellitus. Curr Diabetes Rev 2017;13:533-543.
  • 16. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report):555-576.
  • 17. American Diabetes Association. Standards of medical care in diabetes--2012. Diabetes Care 2012;35(Suppl 1):11-63.
  • 18. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S; IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007;8:299-306.
  • 19. Maffeis C, Birkebaek NH, Konstantinova M, Schwandt A, Vazeou A, Casteels K, Jali S, Limbert C, Pundziute-Lycka A, Toth-Heyn P, de Beaufort C, Sumnik Z, Cherubini V, Svensson J, Pacaud D, Kanaka- Gantenbein C, Shalitin S, Bratina N, Hanas R, Alonso GT, Poran L, Pereira AL, Marigliano M; SWEET Study Group. Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: Data from the international SWEET registry. Pediatr Diabetes 2018;19:1211-1220. Epub 2018 Aug 22
  • 20. Łuczyński W, Szypowska A, Głowińska-Olszewska B, Bossowski A. Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy. Eur J Pediatr 2011;170:891-898. Epub 2010 Dec 8
  • 21. Çelmeli G, Çürek Y, Arslan Gülten Z, Yardımsever M, Koyun M, Akçurin S, Bircan İ. Remarkable Increase in the Prevalence of Overweight and Obesity Among School Age Children in Antalya, Turkey, Between 2003 and 2015. J Clin Res Pediatr Endocrinol 2019;11:76-81. Epub 2018 Sep 25
  • 22. Deniz S, Oguzoncul AF. The prevalence of obesıty and related factors among prımary and secondary school students. Niger J Clin Pract 2019;22:1685-1692.
  • 23. Alper Z, Ercan İ, Uncu Y. A Meta-Analysis and an Evaluation of Trends in Obesity Prevalence among Children and Adolescents in Turkey: 1990 through 2015. J Clin Res Pediatr Endocrinol 2018;10:59-67. Epub 2017 Sep 13
  • 24. Yayıcı Köken Ö, Kara C, Can Yılmaz G, Aydın HM. Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program. J Clin Res Pediatr Endocrinol 2020;12:55-62. Epub 2019 Aug 22
  • 25. Özkaya V, Eren E, Özgen Özkaya Ş, Denkboy Öngen Y. Prevalence of obesity in prepubertal and pubertal with Turkish population type 1 diabetes. Diabetol Int 2021;12:412-419.
  • 26. Purnell JQ, Zinman B, Brunzell JD; DCCT/EDIC Research Group. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 2013;127:180-187.
  • 27. Lobstein T BH. Atlas of childhood obesity. World Obesity Federation, 2019.
  • 28. Ingberg CM, Särnblad S, Palmér M, Schvarcz E, Berne C, Aman J. Body composition in adolescent girls with type 1 diabetes. Diabet Med 2003;20:1005-1011.
  • 29. Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999;48:2039-2044.
  • 30. Colom C, Rull A, Sanchez-Quesada JL, Pérez A. Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk. J Clin Med 2021;10:1798.
  • 31. Järvisalo MJ, Putto-Laurila A, Jartti L, Lehtimäki T, Solakivi T, Rönnemaa T, Raitakari OT. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002;51:493-498.
  • 32. Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 2004;145:452-457.
  • 33. Ahmadizar F, Souverein P, de Boer A, Maitland-van der Zee AH. Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. Br J Clin Pharmacol 2018;84:776-785. Epub 2018 Jan 25
  • 34. Koebnick C, Imperatore G, Jensen ET, Stafford JM, Shah AS, Mottl AK, Bell RA, Dabelea D, Liese AD, Marcovina SM, D’Agostino RB Jr, Urbina EM, Lawrence JM. Progression to hypertension in youth and young adults with type 1 or type 2 diabetes: The SEARCH for Diabetes in Youth Study. J Clin Hypertens (Greenwich) 2020;22:888-896. Epub 2020 Apr 15
  • 35. Downie ML, Ulrich EH, Noone DG. An Update on Hypertension in Children With Type 1 Diabetes. Can J Diabetes 2018;42:199-204. Epub 2018 Mar 6
  • 36. Barstad LH, Júlíusson PB, Johnson LK, Hertel JK, Lekhal S, Hjelmesæth J. Gender-related differences in cardiometabolic risk factors and lifestyle behaviors in treatment-seeking adolescents with severe obesity. BMC Pediatr 2018;18:61.
  • 37. Daratha KB, Bindler RC. Effects of individual components, time, and sex on prevalence of metabolic syndrome in adolescents. Arch Pediatr Adolesc Med 2009;163:365-370.
  • 38. Hero C, Rawshani A, Svensson AM, Franzén S, Eliasson B, Eeg-Olofsson K, Gudbjörnsdottir S. Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes. Diabetes Care 2016;39:996-1003. Epub 2016 Apr 18
  • 39. Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes Dyslipidemia. Diabetes Ther 2016;7:203-219. Epub 2016 Apr 7
  • 40. Schwab KO, Doerfer J, Marg W, Schober E, Holl RW; DPV Science Initiative and the Competence Network Diabetes mellitus. Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors. Pediatr Diabetes 2010;11:357-363.
  • 41. Orchard TJ, Forrest KY, Kuller LH, Becker DJ; Pittsburgh Epidemiology of Diabetes Complications Study. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2001;24:1053-1059.
  • 42. Glaser NS, Geller DH, Haqq A, Gitelman S, Malloy M; Lawson Wilkins Pediatric Endocrine Society Committee on Drugs and Therapeutics. Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population? Pediatr Diabetes 2011;12:442-459. Epub 2010 Nov 5
  • 43. Reh CM, Mittelman SD, Wee CP, Shah AC, Kaufman FR, Wood JR. A longitudinal assessment of lipids in youth with type 1 diabetes. Pediatr Diabetes 2011;12:365-371. Epub 2011 Mar 11
  • 44. Kershnar AK, Daniels SR, Imperatore G, Palla SL, Petitti DB, Pettitt DJ, Marcovina S, Dolan LM, Hamman RF, Liese AD, Pihoker C, Rodriguez BL. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 2006;149:314-319.
  • 45. Macedoni M, Hovnik T, Plesnik E, Kotnik P, Bratina N, Battelino T, Groselj U. Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes. Atherosclerosis 2018;273:53-58. Epub 2018 Apr 12
  • 46. Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr 2017;6:397-407.
  • 47. Harjutsalo V, Maric-Bilkan C, Forsblom C, Groop PH. Impact of sex and age at onset of diabetes on mortality from ischemic heart disease in patients with type 1 diabetes. Diabetes Care 2014;37:144-148. Epub 2013 Sep 23
  • 48. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003;46:760-765. Epub 2003 May 28
  • 49. van Vliet M, Van der Heyden JC, Diamant M, Von Rosenstiel IA, Schindhelm RK, Aanstoot HJ, Veeze HJ. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 2010;156:923-929. Epub 2010 Mar 10
  • 50. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
  • 51. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-1656.
  • 52. Brown TL, Maahs DM, Bishop FK, Snell-Bergeon JK, Wadwa RP. Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes. Int J Pediatr Endocrinol 2016;2016:8. Epub 2016 Apr 19
  • 53. Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O, Beyer P, Holl RW; DPV Initiative of the German Working Group for Pediatric Diabetology. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006;29:218-225.
  • 54. Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jørgensen K; Norwegian Study Group for Childhood Diabetes. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 2008;51:554-561. Epub 2008 Jan 15
  • 55. MacKenzie KE, Wiltshire EJ, Peña AS, Gent R, Hirte C, Piotto L, Couper JJ. Hs-CRP is associated with weight, BMI, and female sex but not with endothelial function in children with type 1 diabetes. Pediatr Diabetes 2009;10:44-51. Epub 2008 Sep 15
  • 56. EUGenMed Cardiovascular Clinical Study Group; Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, Maas AH, Kautzky-Willer A, Knappe-Wegner D, Kintscher U, Ladwig KH, Schenck-Gustafsson K, Stangl V. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J 2016;37:24-34. Epub 2015 Nov 3
  • 57. Hsu SP, Lee WS. Effects of female sex hormones on the development of atherosclerosis. Chin J Physiol 2020;63:256-262.
  • 58. Huxley RR, Peters SA, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015;3:198-206. Epub 2015 Feb 6
  • 59. Smigoc Schweiger D, Battelino T, Groselj U. Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes. Int J Mol Sci 2021;22:10192.
  • 60. Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, Rewers M. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes 2011;60:306-314. Epub 2010 Oct 26
  • 61. Millstein RJ, Pyle LL, Bergman BC, Eckel RH, Maahs DM, Rewers MJ, Schauer IE, Snell-Bergeon JK. Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort. J Diabetes Complications 2018;32:418-423. Epub 2018 Jan 10
  • 62. Hoffman RP, Vicini P, Sivitz WI, Cobelli C. Pubertal adolescent male- female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model. Pediatr Res 2000;48:384-388.
APA Vuralli D, JALILOVA L, ALIKASIFOGLU A, Özön Z, Gonc E, Kandemir N (2024). Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. , 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
Chicago Vuralli Dogus,JALILOVA LALA,ALIKASIFOGLU AYFER,Özön Z. Alev,Gonc E. Nazli,Kandemir Nurgun Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. (2024): 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
MLA Vuralli Dogus,JALILOVA LALA,ALIKASIFOGLU AYFER,Özön Z. Alev,Gonc E. Nazli,Kandemir Nurgun Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. , 2024, ss.11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
AMA Vuralli D,JALILOVA L,ALIKASIFOGLU A,Özön Z,Gonc E,Kandemir N Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. . 2024; 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
Vancouver Vuralli D,JALILOVA L,ALIKASIFOGLU A,Özön Z,Gonc E,Kandemir N Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. . 2024; 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
IEEE Vuralli D,JALILOVA L,ALIKASIFOGLU A,Özön Z,Gonc E,Kandemir N "Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences." , ss.11 - 20, 2024. 10.4274/jcrpe.galenos.2023.2023-12-12
ISNAD Vuralli, Dogus vd. "Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences". (2024), 11-20. https://doi.org/10.4274/jcrpe.galenos.2023.2023-12-12
APA Vuralli D, JALILOVA L, ALIKASIFOGLU A, Özön Z, Gonc E, Kandemir N (2024). Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. Journal of Clinical Research in Pediatric Endocrinology, 16(1), 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
Chicago Vuralli Dogus,JALILOVA LALA,ALIKASIFOGLU AYFER,Özön Z. Alev,Gonc E. Nazli,Kandemir Nurgun Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. Journal of Clinical Research in Pediatric Endocrinology 16, no.1 (2024): 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
MLA Vuralli Dogus,JALILOVA LALA,ALIKASIFOGLU AYFER,Özön Z. Alev,Gonc E. Nazli,Kandemir Nurgun Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. Journal of Clinical Research in Pediatric Endocrinology, vol.16, no.1, 2024, ss.11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
AMA Vuralli D,JALILOVA L,ALIKASIFOGLU A,Özön Z,Gonc E,Kandemir N Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. Journal of Clinical Research in Pediatric Endocrinology. 2024; 16(1): 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
Vancouver Vuralli D,JALILOVA L,ALIKASIFOGLU A,Özön Z,Gonc E,Kandemir N Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. Journal of Clinical Research in Pediatric Endocrinology. 2024; 16(1): 11 - 20. 10.4274/jcrpe.galenos.2023.2023-12-12
IEEE Vuralli D,JALILOVA L,ALIKASIFOGLU A,Özön Z,Gonc E,Kandemir N "Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences." Journal of Clinical Research in Pediatric Endocrinology, 16, ss.11 - 20, 2024. 10.4274/jcrpe.galenos.2023.2023-12-12
ISNAD Vuralli, Dogus vd. "Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences". Journal of Clinical Research in Pediatric Endocrinology 16/1 (2024), 11-20. https://doi.org/10.4274/jcrpe.galenos.2023.2023-12-12